Luzio, S., Tatovic, D., McAteer, M. A., Barry, J., Barrientos, A., Terradillos, K. R., . . . Cheung, I. (2022). Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes. Immunotherapy Advances, 2(1), . doi:10.1093/immadv/ltac002
Chicago Style CitationLuzio, Steve, et al. "Safety of the Use of Gold Nanoparticles Conjugated With Proinsulin Peptide and Administered By Hollow Microneedles As an Immunotherapy in Type 1 Diabetes." Immunotherapy Advances 2, no. 1 (2022).
MLA CitationLuzio, Steve, et al. "Safety of the Use of Gold Nanoparticles Conjugated With Proinsulin Peptide and Administered By Hollow Microneedles As an Immunotherapy in Type 1 Diabetes." Immunotherapy Advances 2.1 (2022).